Avamis – nasal spray of therapeutic action against allergic rhinitis. Contains a fluorinated corticosteroid. The main component of the drug is fluticasone furoate, which has a pronounced anti-inflammatory effect.
The drug is used as a symptomatic therapy in patients, allergic rhinitis.
Nasal allergy - inflammation of the nasal mucosa, accompanied by breathing, abundant mucous secretions and sneezing. At the heart of the pathological process of allergic reaction.
Cause of allergic rhinitis (like any other types of allergic reactions) is a violation of the immune system, which excessively reacts to microscopic particles inhaled. Excessive response of the immune system and causes a typical symptoms.
Adults and adolescents over the age of 12 years are usually assigned according to 2 doses of the drug in each nasal passage 1 once a day. After achieving the desired therapeutic effect, the dose is reduced to 1 injection into each nasal passage 1 once a day.
The maximum daily dose of the drug is 110mcg, maintenance daily dose - 55 mcg. Children aged 6 to 12 years are usually assigned according to 1 dose of the drug in each nasal passage 1 once a day. If necessary, the dose can be increased to 2 injections into each nasal passage 1 once a day, and after achieving the desired therapeutic effect, they will return to the initial dose.
Vial design
The nasal metered spray consists of a glass vial, placed in a plastic case with a protective cap, covering the spray tip (special device at the upper end of the spray). There are small holes in the bottom of the case., through which you can see the presence of the drug in a glass vial. On one side of the plastic housing is a large dosing button, when pressed, the drug is released through the nebulizer.
Preparation for use
Preparation is needed when using Avamys spray for the first time, and also if the vial was left open for a long time. This is necessary for injecting a standard dose of the drug. Preparation includes the following rules:
Application of Avamys nasal spray
Caring for a bottle of Avamys nasal spray
After each use, it is necessary to clean the tip of the vial to preserve its functions., as well as removing excess contaminants:
If the vial of Avamys does not work
Currently reported drug overdose were reported. When using excessive doses of the drug, the patient's condition should be monitored. No specific antidote. In case of overdose, symptomatic therapy is indicated..
When using the drug Avamys, various side effects were noted in patients..
From the respiratory system:
Allergic reactions:
Nervous system: headache.
organs of vision: transient visual impairment (transient blindness or decreased vision in one (two) eye).
With prolonged use of the drug in children, growth retardation may develop..
According to a clinical study on the assessment of the growth of adolescent children, receiving 110 mcg fluticasone furoate once daily, наблюдалась разница в скорости роста – 0,27 cm per year compared to the group, placebo.
Individual hypersensitivity to the drug. The drug is contraindicated in patients, treated with ritonavir. The drug is not used to treat children under the age of 6 years. The drug should be used with caution in patients, suffering from severe liver dysfunction.
There is very little information on the use of the drug during pregnancy and lactation.. During pregnancy and lactation, the active substance fluticasone furoate can only be used as a last resort., if the attending physician considers, that the therapeutic effect of the drug is greater for the mother, than the likelihood of a threat to the child.
With intranasal use of fluticasone furoate at the maximum recommended doses (110 g / day) reaches its concentration, which is generally not measurable, and therefore the potential for reproductive toxicity is expected to be very low. The penetration of fluticase furoate into human breast milk has not been studied.. Human fertility data not available.
Structure:1 dose of Avamys contains: fluticasone furoate - 27.5 mcg.
Excipients: benzalkonium chloride solution.
Spray nasal for 30 or 120 doses in dark glass vials, by 1 vial with nasal adapter and cap in carton box.
Avamis - medicated nasal spray, which contains fluorinated corticosteroids.
The main active ingredient of the drug is fluticasone furoate., with strong anti-inflammatory properties. With intranasal use of a single dose, the systemic bioavailability of the drug is about 0,5%. When using the drug at a dose of 110 mcg 1 once a day, the plasma concentration of the drug is negligible and cannot be measured. The drug binds to plasma proteins within 99%. Breaks down when it enters the liver with the help of the CYP3A4 cytochrome P450 enzyme to form inactive degradation products. Excreted most often through feces.
The drug is recommended to be stored in a dry place away from direct sunlight at a temperature of 15 to 25 degrees Celsius. Shelf life - 3 year. After the first use of the drug, the shelf life is 2 of the month.
Sales form: over-the-counter
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More